Trials / Completed
CompletedNCT02880670
Pharmacokinetics and Metabolism Study of Radiolabeled BMS-986142 in Healthy Male Subjects
Pharmacokinetics and Metabolism of [14C] BMS-986142 in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This is an open-label, single-dose, study in healthy males. The primary objective is to assess the pharmacokinetics (PK), metabolism, and routes of elimination of a single oral dose of radiolabeled BMS-986142 in healthy male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-986142 |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2016-09-01
- Completion
- 2016-09-01
- First posted
- 2016-08-26
- Last updated
- 2016-11-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02880670. Inclusion in this directory is not an endorsement.